Covestor »

Monte Rosa Therapeutics shares owned by Covestor

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Covestor from 13F filings

Historical chart of Covestor investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Covestor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Covestor

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0k 387 15.50

More positions owned by Covestor

Vanguard Ftse Developed Etf Etf (VEA)
Vanguard Total Stock Mkt Etf Etf (VTI)
Nvidia Corp Common (NVDA)
Vanguard Ftse Emerging Marke Etf (VWO)
Terawulf Common (WULF)
Microsoft Corp Common (MSFT)
Vanguard High Dvd Yield Etf Etf (VYM)
Alphabet Inc-cl A Common (GOOGL)
St Joe Co/the Common (JOE)
Echostar Corp-a Common (SATS)
Direxion Dly S&p 500 Bull 3x Etf (SPXL)
Amazon.com Common (AMZN)
Meta Platforms Inc-class A Class A (META)
Babcock & Wilcox Enterpr Common (BW)
Carpenter Technology Common (CRS)

View all positions for Covestor

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics